METASTATIC NON-CUTANEOUS MELANOMA

Clinical trials for METASTATIC NON-CUTANEOUS MELANOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC NON-CUTANEOUS MELANOMA trials appear

Sign up with your email to follow new studies for METASTATIC NON-CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Major trial tests new drug to stop deadly skin Cancer's return

Disease control Ongoing

This large study is testing if a newer immunotherapy drug, pembrolizumab, is better at preventing melanoma from coming back after surgery than the current standard treatments. It involves over 1,300 patients with stage III or IV melanoma who have had their cancer surgically remov…

Matched conditions: METASTATIC NON-CUTANEOUS MELANOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

METASTATIC NON-CUTANEOUS MELANOMA

Get alerted when new METASTATIC NON-CUTANEOUS MELANOMA trials appear

Major trial tests new drug to stop deadly skin Cancer's return